Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Medical Countermeasures Initiative (MCMi)

About MCMi

                        
                MCMi News and Events
          MCMi Newsletters
          Publications and Reports
          Medical Countermeasure Resources
          What are Medical Countermeasures?
          MCMi History Home
          Emergency Preparedness and Response
          Counterterrorism and Emerging Threats
          Medical Countermeasures Initiative (MCMi)
          About MCMiMedical Countermeasures Initiative (MCMi) About MCMi
  			MCMi is an FDA-wide initiative to coordinate medical countermeasure development, preparedness and response
	
        Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintFDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA ensures that medical countermeasures (MCMs)—including drugs, vaccines and diagnostic tests—to counter these threats are safe, effective, and secure. *More: About MCMi and our history*
Sub-Topic Paragraphs
          In this sectionNews & events on typewriter

                    MCMi news and events
            Medical countermeasure-related news and events, updated almost daily
          
          Examples of MCMs include drugs, vaccines, and devices, such as diagnostic tests and personal protective equipment.
      

            
      Examples of MCMs include drugs, vaccines, and devices, such as diagnostic tests and personal protective equipment.

                    What are medical countermeasures?
            MCMs are FDA-regulated products that may be used in a public health emergency
          More about OCETGraphic representing history of the FDA Medical Countermeasures Initiative (MCMi)

                    MCMi history
            More about MCMi, including history and contact information
          
          Hand holding smartphone with new email notification, with computer in background

                    MCMi newsletters
            Subscribe to MCMi email updates and view previous newsletters
          More about OCETImage representing collaborative partnerships

                    MCMi collaborations
            FDA works with government agencies, non-government organizations, universities, and research centers to support public health preparedness and response efforts
          
          Various images representing activities of the Office of Counterterrorism and Emerging Threats, including law and policy, regulatory science, professional development, and medical countermeasure development and availability

                    Office of Counterterrorism and Emerging Threats (OCET)
            OCET coordinates the MCMi, and is part of the FDA Office of the Chief Scientist. Learn more in FDA Organization.
          Publications and ReportsMCMi Program Update report cover - FY 2022

                    Publications and reports
            View the latest MCM-related reports from FDA, including annual program updates
          MCMi mission areasGavel and stethoscope, representing medical countermeasure-related counterterrorism legislation

                    MCM legal, regulatory & policy framework
            Helping ensure that U.S. laws, regulations, and policies support preparedness and response for potential CBRN and emerging infectious disease threats.
          
          FDA scientist dividing plasma from individuals recently infected with dengue or West Nile viruses into smaller volume samples for distribution. These samples were part of a reference panel FDA created for qualified Zika test manufacturers, to determine if their tests can differentiate flaviviridae antibodies—that is, if the test can accurately show if a person was infected with Zika, dengue or West Nile, as antibodies for these viruses are very similar.

                    MCM regulatory science
            Developing the tools, standards, and approaches to assess MCM safety, efficacy, quality and performance, and helping translate new technology into innovative, safe, and effective MCMs.
          Paragraph Header
              Contact Us
        
      
  Contact Point
              Michael Mair, MPH
Assistant Commissioner for Counterterrorism Policy, and Director, OCET
      
	AskMCMi@fda.hhs.gov
      
	
	
		www.fda.gov/medicalcountermeasures
    Twitter: @FDA_MCMi
              
	
	Hours Available

	
		Office of Counterterrorism and Emerging Threats
    For Updates on Twitter follow
      
  Contact Point Twitter
              @FDA_MCMi

                                                                                  Content current as of:
      06/05/2023
                  
                   
Topic(s)
			  Emergency ResponseAbout MCMi                
                          

                        MCMi News and Events
          MCMi Newsletters
          Publications and Reports
          Medical Countermeasure Resources
          What are Medical Countermeasures?
          MCMi History
 Subscribe
                        Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop